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Fraction	in	a	population	 94.7%	 91.2%	 5.3%	 8.8%	
Mean	age	(y)	 59-62	 56-61	 33-45	 32-48	
Mean	clinical	history	(m)	 6.3	 3.9	 16.8	 15.2	
	
Median	overall	survival	(m)	 	
Surgery	+	radiotherapy	 4.7	 9.9	 7.8	 24	
Surgery	+	
radio/chemotherapy	 	 15	 	 31	
	
Histologic	features	 	
Oligodendroglial	comp.	 18%	 20%	 42%	 54%	
Necrosis	 89%	 90%	 63%	 50%	
	
Genetic	Alterations	 	
IDH1	mutations	 4-7%	 0%	 73-88%	 100%	
p53	mutations	 17-
35%	 19-27%	 60-88%	 76-81%	













Table	2.	Top	Gene	Expression	Differences	Between	APC	and	Mature	Astrocytes	Genes	are	ranked	by	fold	change	in	expression	between	APC	and	mature	stages.	Top	genes	are	listed.	All	genes	have	>2-fold	enrichment	in	astrocytes	over	other	cell	types.	(Table	was	adapted	from	Barres,	2016)		 Gene	 Expression	in	Fetal	Astrocytes	 Expression	in	Mature	Astrocytes	 Fold	Change	
Top	Mature	Astrocyte	Genes	AGXT2L1	 0.1	 238.6	 1,988.6	S100A1	 0.1	 84.9	 849.4	SLC14A1	 0.1	 29.3	 334.6	*TLR4	 0.1	 18.7	 212.9	*HSD17B6	 0.1	 20.5	 204.6	
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